|
2020-12-24
|
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
published
| article-journal
doi:10.1093/neuonc/noaa303
|
|
2021-01-26
|
Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
published
| article-journal
| CC-BY
doi:10.3390/cancers13030466
|
|
2021-02-23
|
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumors
published
| article-journal
doi:10.1158/1078-0432.ccr-20-4256
|
|
2021-05-15
|
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
published
| article-journal
| CC-BY
doi:10.3390/cancers13102400
|
|
2021-06-19
|
Argyrin F Treatment‐Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma
published
| article-journal
| CC-BY-NC-ND
doi:10.1002/adtp.202100078
|
|
2021-08-10
|
Mib1 Expression Is Increased in Meningiomas with Histopathological Evidence of Cns Invasion
unknown status
| post
| CC-BY
doi:10.20944/preprints202108.0221.v1
|
|
2021-12-23
|
Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology and treatment
published
| article-journal
| CC-BY
doi:10.1172/jci.insight.153526
|
|
2022-04-14
|
Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial
published
| article-journal
doi:10.1093/neuonc/noac099
|
|
2023-01-07
|
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial
published
| article-journal
| CC-BY
doi:10.1007/s11060-022-04203-4
|
|
2023-02-27
|
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
published
| article-journal
doi:10.1093/neuonc/noad038
|
|
2023-09-21
|
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative
published
| article-journal
doi:10.1093/neuonc/noad157
|
|
2024-03-12
|
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| article-journal
doi:10.1186/s13046-024-02995-z
|
|
2024-04-03
|
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival
published
| article-journal
doi:10.1093/noajnl/vdae053
|
|
2024-08-07
|
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| article-journal
doi:10.1186/s40478-024-01831-x
|
|
2024-08-15
|
Additional file 7 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692198
|
|
2024-08-15
|
Additional file 4 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692189
|
|
2024-08-15
|
Additional file 8 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692201
|
|
2024-08-15
|
Additional file 12 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692213.v1
|
|
2024-08-15
|
Additional file 9 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692204.v1
|
|
2024-08-15
|
Additional file 9 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692204
|
|
2024-08-15
|
Additional file 10 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692207.v1
|
|
2024-08-15
|
Additional file 11 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692210
|
|
2024-08-15
|
Additional file 4 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26735016.v1
|
|
2021-02-23
|
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumors
published
| article-journal
doi:10.1158/1078-0432.ccr-20-4256
|
|
2022-10-24
|
Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma
published
| article-journal
doi:10.3390/brainsci12111426
|
|
2023-01-06
|
Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
published
| unknown type
doi:10.3390/cancers15020377
|
|
2021-04-24
|
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
published
| article-journal
doi:10.3390/vaccines9050428
|
|
2023-12-20
|
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial
published
| article-journal
doi:10.1200/jco.22.01862
|
|
2024-03-13
|
Additional file 1 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.25397550.v1
|
|
2024-06-18
|
Additional file 1 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26054599.v1
|
|
2024-06-18
|
Additional file 1 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26054599
|
|
2024-08-15
|
Additional file 3 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692186.v1
|
|
2024-08-15
|
Additional file 6 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692195
|
|
2024-08-15
|
Additional file 3 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692186
|
|
2024-08-15
|
Additional file 5 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692192
|
|
2024-08-15
|
Additional file 5 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692192.v1
|
|
2024-08-15
|
Additional file 12 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692213
|
|
2024-08-15
|
Additional file 7 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692198.v1
|
|
2024-08-15
|
Additional file 11 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692210.v1
|
|
2024-08-15
|
Additional file 13 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692216.v1
|
|
2024-08-15
|
Additional file 4 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26735016
|
|
2024-08-15
|
Additional file 5 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26735019.v1
|
|
2022
|
Glioblastom
published
| article-journal
doi:10.1055/a-1727-3018
|
|
2023-01-12
|
EANO guideline on rational molecular testing of gliomas, glioneuronal and neuronal tumors in adults for targeted therapy selection
published
| article-journal
doi:10.1093/neuonc/noad008
|
|
2023-02-14
|
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system
published
| article-journal
doi:10.1093/noajnl/vdad012
|
|
2024-01-26
|
Glioblastom – aktuelle Therapiekonzepte
published
| article-journal
| CC-BY
doi:10.1007/s00761-024-01473-7
|
|
2024-03-13
|
Additional file 1 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.25397550
|
|
2024-06-17
|
CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| article-journal
| CC-BY
doi:10.1186/s13073-024-01341-4
|
|
2024-08-15
|
Additional file 2 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.25397682.v1
|
|
2024-08-15
|
Additional file 4 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692189.v1
|
|
2024-08-15
|
Additional file 6 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692195.v1
|
|
2024-08-15
|
Additional file 2 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.25397682
|
|
2024-08-15
|
Additional file 8 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| v1
| CC-BY
doi:10.6084/m9.figshare.26692201.v1
|
|
2024-08-15
|
Additional file 14 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| component
| CC-BY
doi:10.6084/m9.figshare.26692219
|
|
2024-08-15
|
Additional file 10 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692207
|
|
2024-08-15
|
Additional file 14 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.26692219.v1
|
|
2024-08-15
|
Additional file 13 of Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| graphic
| CC-BY
doi:10.6084/m9.figshare.26692216
|
|
2024-08-15
|
Additional file 2 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.26054761.v1
|
|
2024-08-15
|
Additional file 2 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| component
| CC-BY
doi:10.6084/m9.figshare.26054761
|
|
2024-08-15
|
Additional file 2 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26758381
|
|
2024-08-15
|
Additional file 1 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.26758378.v1
|
|
2024-08-15
|
Additional file 2 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26758381.v1
|
|
2024-08-15
|
Additional file 5 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26758390.v1
|
|
2024-08-15
|
Additional file 7 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26758396
|
|
2024-08-15
|
Additional file 7 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26758396.v1
|
|
2024-08-18
|
CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| stub
| CC-BY
doi:10.6084/m9.figshare.c.7290361
|
|
2024-11-22
|
EANO guideline on molecular testing of meningiomas for targeted therapy selection
published
| article-journal
doi:10.1093/neuonc/noae253
|
|
2024-12-02
|
Additional file 2 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937223
|
|
2024-12-02
|
Additional file 6 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937238.v1
|
|
2024-12-02
|
Additional file 5 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937235.v1
|
|
2024-12-02
|
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| stub
| CC-BY
doi:10.6084/m9.figshare.c.7565171
|
|
2024-08-15
|
Additional file 3 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26735013
|
|
2024-08-15
|
Additional file 3 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26735013.v1
|
|
2024-08-15
|
Additional file 5 of CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26735019
|
|
2024-08-15
|
Additional file 3 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26758384.v1
|
|
2024-08-15
|
Additional file 4 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26758387
|
|
2024-08-15
|
Additional file 6 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26758393
|
|
2024-08-15
|
Additional file 6 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26758393.v1
|
|
2024-08-15
|
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| stub
| v1
| CC-BY
doi:10.6084/m9.figshare.c.7390759.v1
|
|
2024-08-15
|
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| stub
| CC-BY
doi:10.6084/m9.figshare.c.7390759
|
|
2024-08-18
|
CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines
published
| stub
| v1
| CC-BY
doi:10.6084/m9.figshare.c.7290361.v1
|
|
2024-12-02
|
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| article-journal
| CC-BY
doi:10.1186/s13059-024-03438-w
|
|
2024-12-02
|
Additional file 2 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937223.v1
|
|
2024-12-02
|
Additional file 4 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937232
|
|
2024-12-02
|
Additional file 4 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937232.v1
|
|
2024-12-02
|
Additional file 5 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937235
|
|
2024-12-02
|
Additional file 14 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937253
|
|
2024-12-02
|
Additional file 14 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937253.v1
|
|
2024-08-15
|
Additional file 1 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| component
| CC-BY
doi:10.6084/m9.figshare.26758378
|
|
2024-08-15
|
Additional file 4 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.26758387.v1
|
|
2024-08-15
|
Additional file 3 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26758384
|
|
2024-08-15
|
Additional file 5 of Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.26758390
|
|
2024-08-18
|
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| stub
| v1
| CC-BY
doi:10.6084/m9.figshare.c.7118577.v1
|
|
2024-08-18
|
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
published
| stub
| CC-BY
doi:10.6084/m9.figshare.c.7118577
|
|
2024-11-17
|
Frequency and clinical associations of common mental disorders in adults with high‐grade glioma—A multicenter study
published
| article-journal
| CC-BY-NC
doi:10.1002/cncr.35653
|
|
2024-12-02
|
Additional file 3 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937226
|
|
2024-12-02
|
Additional file 1 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937220
|
|
2024-12-02
|
Additional file 1 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937220.v1
|
|
2024-12-02
|
Additional file 7 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937241
|
|
2024-12-02
|
Additional file 15 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937256
|
|
2024-12-02
|
Additional file 18 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937265.v1
|
|
2024-12-02
|
Additional file 15 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937256.v1
|
|
2024-12-02
|
Additional file 9 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937250
|
|
2024-12-02
|
Additional file 19 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937268.v1
|
|
2024-12-02
|
Additional file 17 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937262.v1
|
|
2024-12-02
|
Additional file 7 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937241.v1
|
|
2025-01-16
|
The Immunopeptidomic Landscape of Ependymomas Provides Actionable Antigens for T Cell-Based Immunotherapy
published
| article-journal
doi:10.1093/noajnl/vdae226
|
|
2024-10-01
|
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ
published
| article-journal
doi:10.1093/neuonc/noae205
|
|
2024-12-02
|
Additional file 16 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| v1
| CC-BY
doi:10.6084/m9.figshare.27937259.v1
|
|
2024-12-02
|
Additional file 18 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937265
|
|
2024-12-02
|
Additional file 17 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937262
|
|
2024-12-02
|
Additional file 19 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937268
|
|
2024-12-02
|
Additional file 8 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937244.v1
|
|
2024-12-02
|
Additional file 8 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937244
|
|
2025-01-14
|
Author Response: MR Spectroscopy in a Patient With Isolated Brainstem Posterior Reversible Encephalopathy Syndrome
published
| article-journal
doi:10.1212/wnl.0000000000209514
|
|
2024-12-02
|
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| stub
| v1
| CC-BY
doi:10.6084/m9.figshare.c.7565171.v1
|
|
2024-12-02
|
Additional file 3 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937226.v1
|
|
2024-12-02
|
Additional file 6 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.27937238
|
|
2024-12-02
|
Additional file 16 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| component
| CC-BY
doi:10.6084/m9.figshare.27937259
|
|
2024-12-02
|
Additional file 9 of Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.27937250.v1
|
|
2024-11-19
|
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?
published
| article-journal
doi:10.1093/neuonc/noae225
|
|
2025-01-04
|
Genome-wide CRISPR-Cas9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma
published
| article-journal
doi:10.1093/neuonc/noae278
|